Literature DB >> 21993983

Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension.

Andrew J Swift1, Smitha Rajaram, Helen Marshall, Robin Condliffe, Dave Capener, Catherine Hill, Christine Davies, Judith Hurdman, Charlie A Elliot, Jim M Wild, David G Kiely.   

Abstract

OBJECTIVES: Double inversion recovery (DIR) "black blood" MRI suppresses the signal from flowing blood, slow flowing blood causes incomplete suppression resulting in pulmonary blood flow artefact (PFA). This study examines the diagnostic utility and prognostic value of a PFA scoring system in a mixed cohort of patients with pulmonary hypertension (PH).
METHODS: DIR-MRI images were reviewed for 233 patients referred with suspected PH who underwent right heart catheterisation (RHC) within 48 h of MR. The degree of PFA was visually scored in all patients from 0 to 5 (0 = absent, 1 = segmental, 2 = lobar, 3 = distal main, 4 = proximal main and 5 = trunk). Pulmonary artery (PA), aorta (Ao), and PA main branch diameters were measured from which PA/Ao ratios and mean PA branch diameters (MPAB) were calculated.
RESULTS: PFA >1 demonstrated high sensitivity (86%) and specificity (85%) for the diagnosis PH in our mixed patient cohort. A good correlation was found with PFA and haemodynamic parameters, PVR (r = 0.70), mPAP (r = 0.65) and CI (r = -0.53). PFA predicted mortality (P = 0.005) during the mean follow-up for 19 months. PFA scoring demonstrated good inter-observer agreement (k = 0.83).
CONCLUSIONS: PFA scoring is of diagnostic and prognostic value in the assessment of patients with suspected PH. and is a predictor of mortality. KEY POINTS: • A simple magnetic resonance method of assessing pulmonary blood flow is presented • This involves a qualitative scoring system of black blood pulmonary flow artefacts • This is simple to perform and seems reproducible in pulmonary hypertension patients • The degree of artefact correlates well with right heart catheter measurements • Prominent pulmonary flow artefact predicts mortality in patients with pulmonary hypertension.

Entities:  

Mesh:

Year:  2011        PMID: 21993983     DOI: 10.1007/s00330-011-2306-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

Review 1.  The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension.

Authors:  Gianluca Marrone; Giuseppe Mamone; Angelo Luca; Patrizio Vitulo; Alessandro Bertani; Michele Pilato; Bruno Gridelli
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-25       Impact factor: 2.357

Review 2.  Pulmonary hypertension: role of computed tomography and magnetic resonance imaging.

Authors:  Lucio Di Guglielmo; Roberto Dore; Valentina Vespro
Journal:  Ital Heart J       Date:  2005-10

3.  Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension.

Authors:  Sebastian Ley; Derliz Mereles; Michael Puderbach; Ekkehard Gruenig; Helena Schöck; Monika Eichinger; Julia Ley-Zaporozhan; Christian Fink; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2007-01-16       Impact factor: 5.315

4.  Fast selective black blood MR imaging.

Authors:  R R Edelman; D Chien; D Kim
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

5.  Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Munenobu Nogami; Daisuke Takenaka; Sumiaki Matsumoto; Yumiko Onishi; Keiko Matsumoto; Kenya Murase; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2008-10       Impact factor: 4.813

6.  Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Dan Hagger; Robin Condliffe; Neil Woodhouse; Charlie A Elliot; Iain J Armstrong; Christine Davies; Catherine Hill; Mohammed Akil; Jim M Wild; David G Kiely
Journal:  Rheumatology (Oxford)       Date:  2009-07-14       Impact factor: 7.580

Review 7.  Computed tomography and magnetic resonance imaging of pulmonary hypertension: Pulmonary vessels and right ventricle.

Authors:  Sebastian Ley; Ekkehard Grünig; David G Kiely; Edwin van Beek; Jim Wild
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

8.  Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements.

Authors:  Jean-Philippe Alunni; Bruno Degano; Catherine Arnaud; Laurent Tétu; Nathalie Blot-Soulétie; Alain Didier; Philippe Otal; Hervé Rousseau; Valérie Chabbert
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

9.  Pathologic blood flow in pulmonary vascular disease as shown by gated magnetic resonance imaging.

Authors:  G K von Schulthess; M R Fisher; C B Higgins
Journal:  Ann Intern Med       Date:  1985-09       Impact factor: 25.391

10.  Magnetic resonance imaging in pulmonary arterial hypertension.

Authors:  A Bouchard; C B Higgins; B F Byrd; E G Amparo; L Osaki; R Axelrod
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

View more
  10 in total

Review 1.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

2.  Right ventricular reverse remodeling after pulmonary endarterectomy: magnetic resonance imaging and clinical and right heart catheterization assessment.

Authors:  Marius Berman; Deepa Gopalan; Linda Sharples; Nick Screaton; Caroline Maccan; Karen Sheares; Joanna Pepke-Zaba; John Dunning; Steven Tsui; David P Jenkins
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

3.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

4.  Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.

Authors:  Catherine E Simpson; Todd M Kolb; Steven Hsu; Stefan L Zimmerman; Celia P Corona-Villalobos; Stephen C Mathai; Rachel L Damico; Paul M Hassoun
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

Review 5.  Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art.

Authors:  Andrew J Swift; Jim M Wild; Scott K Nagle; Alejandro Roldán-Alzate; Christopher J François; Sean Fain; Kevin Johnson; Dave Capener; Edwin J R van Beek; David G Kiely; Kang Wang; Mark L Schiebler
Journal:  J Thorac Imaging       Date:  2014-03       Impact factor: 3.000

6.  Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension.

Authors:  Andrew J Swift; Adam Telfer; Smitha Rajaram; Robin Condliffe; Helen Marshall; Dave Capener; Judith Hurdman; Charlie Elliot; David G Kiely; Jim M Wild
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

7.  A social-technological epistemology of clinical decision-making as mediated by imaging.

Authors:  Sophie van Baalen; Annamaria Carusi; Ian Sabroe; David G Kiely
Journal:  J Eval Clin Pract       Date:  2016-10-03       Impact factor: 2.431

8.  The prognostic value of DLCO and pulmonary blood flow in patients with pulmonary hypertension.

Authors:  Stefan Stadler; Nicoletta Mergenthaler; Tobias J Lange
Journal:  Pulm Circ       Date:  2019-12-27       Impact factor: 3.017

9.  Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models.

Authors:  Christopher S Johns; David G Kiely; Smitha Rajaram; Catherine Hill; Steven Thomas; Kavitasagary Karunasaagarar; Pankaj Garg; Neil Hamilton; Roshni Solanki; David A Capener; Charles Elliot; Ian Sabroe; Athanasios Charalamopopoulos; Robin Condliffe; James M Wild; Andrew J Swift
Journal:  Radiology       Date:  2018-10-23       Impact factor: 29.146

Review 10.  The changing face of pulmonary hypertension diagnosis: a historical perspective on the influence of diagnostics and biomarkers.

Authors:  Jenny L Hewes; Ji Young Lee; Karen A Fagan; Natalie N Bauer
Journal:  Pulm Circ       Date:  2020-02-04       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.